Thus, the most novel finding in our studies was that when IL-15 complexes were delivered via the intratumoral route, the cytokine reached the tumor-draining lymph nodes, activating CD8+ T cells and other immune cells and inducing their migration into the TME. The gene discussed is CD8A; the disease is neoplasm.